Compare Moderna, Inc. (MRNA) vs Vertiv Holdings Co (VRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Vertiv Holdings Co — how do they compare? Moderna, Inc. trades at $59.68 (market cap $23.60B), while Vertiv Holdings Co trades at $305.01 (market cap $112.03B). The key difference: Vertiv Holdings Co is far larger — about 4.7× Moderna, Inc.'s market cap, and Vertiv Holdings Co pays a 0.09% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | VRT | |
|---|---|---|
Market Cap | $23.60B | $112.03B |
Sector | Health | Technology |
52-Week High | $81.80 | $376.23 |
52-Week Low | $22.36 | $121.82 |
Enterprise Value | $19.70B | $112.80B |
Dividend Yield | — | 0.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Vertiv Holdings Co
Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →
